CO4940452A1 - Modificacion a cristal de una sustancia activa de medicamen- to - Google Patents

Modificacion a cristal de una sustancia activa de medicamen- to

Info

Publication number
CO4940452A1
CO4940452A1 CO98032879A CO98032879A CO4940452A1 CO 4940452 A1 CO4940452 A1 CO 4940452A1 CO 98032879 A CO98032879 A CO 98032879A CO 98032879 A CO98032879 A CO 98032879A CO 4940452 A1 CO4940452 A1 CO 4940452A1
Authority
CO
Colombia
Prior art keywords
crystal modification
medicinal substance
active medicinal
modification
difluorbenzyl
Prior art date
Application number
CO98032879A
Other languages
English (en)
Spanish (es)
Inventor
Robert Portmann
Christoph Hofmeier Urs
Andreas Burkhard
Walter Scherrer
Martin Szelagiewcz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4940452(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO4940452A1 publication Critical patent/CO4940452A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO98032879A 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia activa de medicamen- to CO4940452A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
CO4940452A1 true CO4940452A1 (es) 2000-07-24

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
CO98032879A CO4940452A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia activa de medicamen- to
CO98032885A CO4940448A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia de medicamento

Family Applications After (1)

Application Number Title Priority Date Filing Date
CO98032885A CO4940448A1 (es) 1997-06-10 1998-06-09 Modificacion a cristal de una sustancia de medicamento

Country Status (36)

Country Link
US (6) US6740669B1 (enExample)
EP (2) EP0994864B1 (enExample)
JP (2) JP3672574B2 (enExample)
KR (2) KR100425656B1 (enExample)
CN (3) CN1298708C (enExample)
AR (4) AR012946A1 (enExample)
AT (2) ATE232852T1 (enExample)
AU (2) AU725517B2 (enExample)
BR (2) BR9804947A (enExample)
CA (3) CA2256013C (enExample)
CO (2) CO4940452A1 (enExample)
CY (1) CY2007014I1 (enExample)
CZ (2) CZ292260B6 (enExample)
DE (3) DE69811500T2 (enExample)
DK (2) DK0994863T3 (enExample)
ES (2) ES2197485T3 (enExample)
FR (1) FR07C0037I2 (enExample)
HU (2) HU226107B1 (enExample)
ID (2) ID21014A (enExample)
IL (2) IL125732A (enExample)
LU (1) LU91345I2 (enExample)
MY (2) MY120156A (enExample)
NL (1) NL300284I2 (enExample)
NO (2) NO329315B1 (enExample)
NZ (2) NZ331371A (enExample)
PE (2) PE79799A1 (enExample)
PL (2) PL192114B1 (enExample)
PT (1) PT994864E (enExample)
RU (2) RU2194041C2 (enExample)
SI (2) SI0994864T1 (enExample)
SK (2) SK283685B6 (enExample)
TR (2) TR199801630T1 (enExample)
TW (2) TW403740B (enExample)
UY (1) UY25844A1 (enExample)
WO (2) WO1998056772A1 (enExample)
ZA (2) ZA984966B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
PE20040538A1 (es) * 2002-05-31 2004-08-30 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
NZ591725A (en) * 2008-10-13 2012-09-28 Cipla Ltd PROCESS FOR THE PREPARATION OF RUFINAMIDE which is also known as 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
US8377973B2 (en) * 2009-09-04 2013-02-19 Tactical Therapeutics Inc Compositions and processes for preparing 5-amino or substituted amino 1,2,3-triazoles and triazole orotate formulations
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
WO2011135105A1 (en) * 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A7 (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
AU656154B2 (en) 1990-11-06 1995-01-27 Astellas Pharma Inc. Fused pyrazine derivative
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
CN1072215C (zh) 1995-02-22 2001-10-03 赫彻斯特药品和化学品公司 无定形吡咯他尼、吡咯他尼多晶型物,其制备方法和用途
SK283990B6 (sk) * 1996-07-11 2004-07-07 Novartis Ag Spôsob prípravy 1-substituovaných 4-kyano-1,2,3-triazolov, 4-kyano-1-(2,6-difluórbenzyl)-1H-1,2,3-triazol
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide

Also Published As

Publication number Publication date
CZ253398A3 (cs) 1999-04-14
KR19990087835A (ko) 1999-12-27
JP2000516259A (ja) 2000-12-05
US20060116520A1 (en) 2006-06-01
KR19990087836A (ko) 1999-12-27
NZ331371A (en) 2000-08-25
HK1028241A1 (en) 2001-02-09
ID21014A (id) 1999-04-08
DE69811500T2 (de) 2004-04-01
US7750028B2 (en) 2010-07-06
HK1028242A1 (en) 2001-02-09
AR061004A2 (es) 2008-07-30
DK0994864T3 (da) 2003-07-21
LU91345I2 (fr) 2007-09-04
SI0994863T1 (en) 2003-08-31
IL125733A0 (en) 1999-04-11
HUP0000798A3 (en) 2000-10-30
AR012946A1 (es) 2000-11-22
US20030125568A1 (en) 2003-07-03
CA2256013A1 (en) 1998-12-17
NO329315B1 (no) 2010-09-27
CN1132820C (zh) 2003-12-31
TW403740B (en) 2000-09-01
CY2007014I2 (el) 2009-11-04
ZA984967B (en) 1999-01-11
DE69811500D1 (de) 2003-03-27
WO1998056772A1 (en) 1998-12-17
NO329314B1 (no) 2010-09-27
CO4940448A1 (es) 2000-07-24
SK283685B6 (sk) 2003-12-02
FR07C0037I2 (enExample) 2008-05-16
TR199801631T1 (xx) 1999-06-21
MY125854A (en) 2006-08-30
US6740669B1 (en) 2004-05-25
US20040167186A1 (en) 2004-08-26
PL330764A1 (en) 1999-05-24
DE69813560T2 (de) 2004-02-05
ATE232852T1 (de) 2003-03-15
TW526195B (en) 2003-04-01
CA2256013C (en) 2007-10-16
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
CA2614926A1 (en) 1998-12-17
NO983666L (no) 1998-12-17
NO983667L (no) 1998-12-17
ZA984966B (en) 1999-01-11
MY120156A (en) 2005-09-30
IL125732A (en) 2002-12-01
PL192114B1 (pl) 2006-08-31
NL300284I2 (nl) 2007-11-01
PL330798A1 (en) 1999-06-07
PL191943B1 (pl) 2006-07-31
EP0994864A1 (en) 2000-04-26
KR100409168B1 (ko) 2004-01-31
TR199801630T1 (xx) 1999-06-21
CN1217716A (zh) 1999-05-26
HK1028031A1 (en) 2001-02-02
CZ292481B6 (cs) 2003-09-17
JP3672574B2 (ja) 2005-07-20
CA2256015A1 (en) 1998-12-17
CN1159300C (zh) 2004-07-28
EP0994863B1 (en) 2003-02-19
SK109398A3 (en) 1998-12-02
JP2000516258A (ja) 2000-12-05
HU225153B1 (en) 2006-07-28
EP0994863A1 (en) 2000-04-26
HUP0002113A3 (en) 2002-09-30
AU8437198A (en) 1998-12-30
CY2007014I1 (el) 2009-11-04
KR100425656B1 (ko) 2004-05-17
HUP0000798A2 (hu) 2000-10-30
AU8437298A (en) 1998-12-30
ES2192779T3 (es) 2003-10-16
IL125732A0 (en) 1999-04-11
US20100310655A1 (en) 2010-12-09
AR012945A1 (es) 2000-11-22
CN1259127A (zh) 2000-07-05
HU226107B1 (en) 2008-04-28
RU2194041C2 (ru) 2002-12-10
US8076362B2 (en) 2011-12-13
DE69813560D1 (de) 2003-05-22
AU725528B2 (en) 2000-10-12
US20010037029A1 (en) 2001-11-01
ES2197485T3 (es) 2004-01-01
BR9804946A (pt) 1999-08-24
SI0994864T1 (en) 2003-10-31
LU91345I9 (enExample) 2018-12-31
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
US6455556B2 (en) 2002-09-24
FR07C0037I1 (enExample) 2007-08-17
SK109498A3 (en) 1998-12-02
JP3672575B2 (ja) 2005-07-20
CZ292260B6 (cs) 2003-08-13
HUP0002113A2 (hu) 2001-02-28
PE79799A1 (es) 1999-09-03
EP0994864B1 (en) 2003-04-16
CZ253498A3 (cs) 1999-04-14
ID27660A (id) 2001-04-19
CA2256015C (en) 2008-06-03
BR9804947A (pt) 1999-08-24
CN1298708C (zh) 2007-02-07
AR061005A2 (es) 2008-07-30
CA2614926C (en) 2010-02-09
PE80999A1 (es) 1999-09-06
RU2198167C2 (ru) 2003-02-10
NZ331370A (en) 2000-08-25
NO983666D0 (no) 1998-08-11
DK0994863T3 (da) 2003-05-26
IL125733A (en) 2002-12-01
UY25844A1 (es) 2001-08-27
CN1572789A (zh) 2005-02-02
PT994864E (pt) 2003-07-31
DE122007000051I1 (de) 2007-11-08
DE122007000051I2 (de) 2009-02-19
AU725517B2 (en) 2000-10-12
ATE237599T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
SE8804629D0 (sv) New therapeutically active compounds
SE9504661D0 (sv) New compounds
CO4940452A1 (es) Modificacion a cristal de una sustancia activa de medicamen- to
ES2084702T3 (es) Imidazoles sustituidos utiles como inhibidores de la angiotensina ii.
ATE260646T1 (de) Schnell zerfallende orale dosierungsform
ATE191468T1 (de) Metalloproteinase inhibitoren
BR9714354A (pt) Oxadiazóis, processos para sua preparação e seu emprego como medicamentos
EA200200571A1 (ru) Новая композиция и ее применение
DK581889A (da) Antiatherosclerotiske diarylforbindelser
SE8804628D0 (sv) New compounds
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
ATE360428T1 (de) Analgetisches arzneimittel
LV10267A (lv) Savienojums arstniecibas lidzeklis panemiens savienojuma iegusanai
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
SE9504662D0 (sv) New compounds
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
NO950177D0 (no) Farmakologisk aktive erivater
SE9504267D0 (sv) New therapeutic use
ATE248163T1 (de) Neuartige, pharmazeutisch aktive verbindung
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
RU95102147A (ru) Производные 1-[2-(1н-инден-3-ил)этил]-4-(нафт-1-ил)пиперазина, способ их получения и содержащие их медикамент и фармацевтический состав
EA200400709A1 (ru) Ингибиторы 11-бета-гидроксистероиддегидрогеназы типа 1
NO170151C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(1-aryl-2-hydroksyetyl)-imidazoler og salter derav
ECSP982521A (es) Modificacion a cristal de una sustancia activa de medicamento (i)